Trials
Search / Trial NCT06441370

Patient Satisfaction During Physiological Water or Land Birth: a Prospective Study in an French Tertiary Maternity Unit.

Launched by TOURCOING HOSPITAL · May 28, 2024

Trial Information

Current as of February 19, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is investigating how satisfied women feel after giving birth in water compared to those who give birth on land. The goal is to understand the benefits of water birth and show how it can be a valuable option for expectant mothers. The study will take place in a French maternity unit and is currently looking for participants.

To be eligible for the trial, women must be at least 18 years old, have social security coverage, and choose to have a water birth after reaching at least 37 weeks of pregnancy. They should also be in spontaneous labor and have the baby in a head-down position. However, women with certain health conditions, previous complications during labor, or those needing pain relief like an epidural will not be included in the study. Participants can expect to share their experiences and feelings about their birth, helping researchers understand the impact of water birth on overall satisfaction and mental well-being.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Major patient
  • Social security beneficiary
  • Presence of a companion
  • Delivery greater than or equal to 37 weeks of amenorhoea
  • Spontaneous labor
  • Cephalic presentation
  • Physiological delivery by woman's choice according to 2017 HAS criteria (French recommendations)
  • Exclusion Criteria:
  • Patient under court protection
  • Patient under guardianship or curatorship
  • Placement of an epidural
  • Language barrier
  • Unexpected delivery (unwanted by the woman)
  • Scarred uterus
  • Meconium fluid
  • Maternal pathologies: epilepsy, MS (depending on neurological opinion), diabetes (types 1 and 2), herpes infection, HIV, HBV, HCV
  • History of delivery hemorrhage \> 1L
  • History of shoulder dystocia/clavicle fracture
  • Metrorrhagia
  • Administration of nalbuphine within 2 hours of birth.

Trial Officials

GOBERT JG julia, MD

Principal Investigator

Tourcoing Hospital

GAILLARD JG Julie

Principal Investigator

Tourcoing Hospital

About Tourcoing Hospital

Tourcoing Hospital is a renowned healthcare institution dedicated to advancing medical research and patient care. As a clinical trial sponsor, it focuses on innovative studies that enhance treatment outcomes and improve healthcare practices. With a commitment to ethical standards and patient safety, Tourcoing Hospital collaborates with multidisciplinary teams of healthcare professionals to conduct rigorous clinical trials across various medical fields. Its state-of-the-art facilities and expertise in clinical research support the development of new therapies and contribute to the broader medical community's knowledge.

Locations

Tourcoing, Hauts De France, France

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0